knowledge -WSS

knowledge

author：explore 2025-09-27 13:10:57 - browse：8414

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： CDC concerned about possible undetected monkeypox spread in U.K.

WSS

Why are elite athletes different? Take a look at their microbes

2 US Navy sailors arrested for allegedly spying for China

Disclosing genetic information: not as worrisome as once feared

With FDA staff opposed to Sarepta therapy, top official intervened

What Mike Pence has said that could be used in a Donald Trump trial

CDC concerned about possible undetected monkeypox spread in U.K.

leisure time

knowledge

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Hepatitis C has a cure — but many Americans still lack access to it

Disclosing genetic information: not as worrisome as once feared

Jerome Adams on the need for new antivirals for Covid

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Walensky prepares to leave CDC — and Congress — behind

Dramatically reducing cancer deaths requires the PASTEUR Act

Hollywood unions extend contract negotiations for actors

Do masks work? RCTs can't tell us

hotspot

Cloning humans is technically possible. It's curious no one has tried

What Mike Pence has said that could be used in a Donald Trump trial

White House drug shortage group privately met with industry

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

'Ancient DNA,' 23andMe reveal African American ancestries

leisure time

Wikipedia

focus

knowledge